SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 30 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $141,627,000 | +74.7% | 38,036,000 | +16.7% | 2.82% | +78.9% |
| Q4 2014 | $81,057,000 | -27.1% | 32,588,000 | -1.5% | 1.58% | -32.0% |
| Q3 2014 | $111,210,000 | +248.7% | 33,088,000 | +177.0% | 2.32% | +232.2% |
| Q2 2014 | $31,896,000 | +76.2% | 11,943,000 | +48.0% | 0.70% | +80.2% |
| Q1 2014 | $18,107,000 | – | 8,070,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 219,440,000 | $585,836,000 | 7.18% |
| SYMPHONY ASSET MANAGEMENT LLC | 11,727,000 | $31,333,000 | 3.26% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 28,200,000 | $75,347,000 | 0.92% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,943,000 | $31,896,000 | 0.70% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 600,000 | $1,606,000 | 0.62% |
| BNP PARIBAS FINANCIAL MARKETS | 1,200,000 | $320,628,000,000 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 3,000,000 | $7,998,000 | 0.10% |
| Visium Asset Management, LP | 2,000,000 | $5,335,000 | 0.08% |
| SG Americas Securities, LLC | 22,800 | $6,103,000 | 0.04% |
| LORD, ABBETT & CO. LLC | 10,988,000 | $29,414,000 | 0.03% |